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Abstract:  Two new compounds, asperversin A (1) and 9ξ-O-2(2,3-dimethylbut-3-
enyl)brevianamide Q (2), and nine known compounds, brevianamide K (3), brevianamide 
M (4), aversin (5), 6,8-di-O-methylnidurufin (6), 6,8-di-O-methylaverufin (7),  
6-O-methylaverufin (8), 5α,8α-epidioxyergosta-6,22-dien-3β-ol (9), ergosta-7,22-diene-
3β,5α,6β-triol (10), and 6β-methoxyergosta-7,22-diene-3β,5α-diol (11), were obtained 
from the culture of Aspergillus versicolor, an endophytic fungus isolated from the marine 
brown alga Sargassum thunbergii. The structures of these compounds were established by 
spectroscopic techniques. Compounds 4, 7 and 8 exhibited antibacterial activities against 
Escherichia coli and Staphyloccocus aureus, and 7 also showed lethality against brine 
shrimp (Artemia salina) with an LC50 value of 0.5 μg/mL. 
Keywords:  Sargassum thunbergii;  Aspergillus versicolor; asperversin A;   
9ξ-O-2(2,3-dimethylbut-3-enyl)brevianamide Q 
 
1. Introduction 
As primary producers, marine algae are faced with a variety of survival stresses, including predation 
and diseases caused by microorganisms. Algicolous fungi, which are widespread among marine algae, 
are proposed to play important ecological adaptations for the host that include providing increased 
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resistance against biotic stresses. These protective effects are thought to be mediated by fungal-derived 
natural products, which makes algicolous fungi and their secondary metabolites a valuable resource for 
new bioactive compound discovery [1,2]. 
Figure 1. Structures of compounds 1–11. 
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The brown alga  Sargassum thunbergii is distributed widely throughout the marine environment 
surrounding eastern China and it is recognized for its ability to generate large quantities of biomass.  
In our program focused on the identification of new and bioactive compounds from marine algae and 
their associated fungi, endophytic fungi from S. thunbergii (collected near Pingtan Island) were 
selected for chemical investigations. In the course of these studies, a strain of Aspergillus versicolor 
(strain designation pt20) was isolated from the inner tissue of S. thunbergii. Our chemical   
investigation of this strain resulted in the identification of two new compounds, asperversin A (1) and 
9ξ-O-2(2,3-dimethylbut-3-enyl)brevianamide Q (2), as well as nine known compounds that included 
brevianamide K (3) [3], brevianamide M (4) [3], aversin (5) [4], 6,8-di-O-methylnidurufin (6) [5],  
6,8-di-O-methylaverufin (7) [6], 6-O-methylaverufin (8) [7], 5α,8α-epidioxyergosta-6,22-dien-3β-ol 
(9) [8], ergosta-7,22-diene-3β,5α,6β-triol (10) [9], and 6β-methoxyergosta-7,22-diene-3β,5α-diol  Mar. Drugs 2012, 10                                                 
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(11) [9]. This paper describes the isolation, structure determination, and bioactivity of   
compounds 1–11 (Figure 1). 
2. Results and Discussion 
Compound 1 was obtained as yellow crystals from CHCl3. The molecular formula was determined 
as C47H58O10 on the basis of HREIMS with the [M]
+ peak at m/z 782.4024 (calcd. for C47H58O10, 
782.4030), indicating nineteen degrees of unsaturation. The 
1H-NMR spectrum (Table 1) displayed 
two tertiary methyl singlets, four secondary methyl doublets, two oxygenated methyl singlets, one 
multiplet and two doublets assignable to three oxygenated methines, four doublets ascribed to two 
mutually coupled olefinic protons and two mutually coupled aromatic protons, two double doublets 
attributed to two mutually coupled olefinic protons, and one singlet characteristic of an aromatic 
proton. The 
13C NMR spectrum (Table 1) along with the DEPT and HSQC experiments revealed the 
presence of eight methyl groups, eight methylenes, seventeen methines, and fourteen quaternary 
carbon atoms. Upon further inspection of the NMR data, it was realized that approximately half of the 
chemical shifts in 1 were superimposeable with 5α,8α-epidioxyergosta-6,22-dien-3β-ol (9), which we 
also isolated from the same fungal extract [8]. This enabled us to focus on the remaining chemical 
shifts in 1, which we were able to deduce had remarkable similarities to the natural product   
5-methoxysterigmatocystin [4]. However, several key differences remained between our NMR data 
and those reported for 5-methoxysterigmatocystin. Namely, our metabolite 1 exhibited new resonances 
for a methylene and an oxygenated methine, but lacked two olefinic methines. Therefore, we deduced 
that this portion of the molecule represented a 3',4'-dihydro-5-methoxysterigmatocystin residue, which 
was verified by the 
1H–
1H COSY correlations between H-6/H-7, H-1'/H-2', H-2'/H-3', H-3'/H-4' and 
HMBC correlations from H-2 to C-1, C-3, C-4, and C-12, from H-6 to C-5, C-8, and   
C-10, from H-7 to C-5, C-8, and C-11, from H-14 to C-5, from H-15 to C-1, from H-1' to C-3, C-4,  
C-2', C-3', and C-4', from H-2' to C-3, C-4, C-13, C-1', C-3', and C-4', and from H-4' to C-1', C-2', and 
C-3'. The linkage between the two portions of compound 1 was established by HMBC correlations 
from H-4' to C-3" and from H-3" to C-4'. The relative configuration of 1 was confirmed by analysis of 
NOESY spectrum. Based on biogenetic considerations, the configurations of steroid moiety should be 
the same as those of 5α,8α-epidioxyergosta-6,22-dien-3β-ol (9) [8], which were confirmed by the 
observed NOESY correlations between H-6"/H-19", H-7"/H-18", H-18"/H-20", H-2"a/H-19",   
H-2"b/H-3". H-3"and H-4' were located on the same side by the NOESY correlation between   
H-3"/H-4', while H-4', H-1', and H-2' were positioned on the same face based on the NOESY 
correlations of H-1' with H-2' and H-4'. We have given this new molecule from A. versicolor pt20 the 
trivial name asperversin A. 
Table 1. 
1H and 
13C NMR data for compound 1  (500 MHz for 
1H and 125 MHz for  
13C, CDCl3). 
Position  δH (J in Hz)  δC, mult.  Position δH(J in Hz)  δC, mult. 
1    163.3, C  6"  6.11, d (8.5)  135.3, CH 
2  6.34, s  90.1, CH  7"  6.44, d (8.5)  130.7, CH 
3    165.3, C  8"    79.4, C 
4    108.2, C  9"  1.44, m  51.1, CH Mar. Drugs 2012, 10                                                 
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Table 1. Cont. 
Position  δH (J in Hz)  δC, mult.  Position δH(J in Hz)  δC, mult. 
5    139.4, C  10"    37.1, C 
6  7.18, d (9.0)  120.4, CH  11"a  1.36, m  20.6, CH2 
7  6.68, d (9.0)  109.3, CH  11"b  1.56, m   
8    155.3, C  12"a  1.20, m  39.3, CH2 
9   181.6,  C  12"b  1.92,  m   
10    144.9, C  13"    44.5, C 
11    109.6, C  14"  1.52, m  51.6, CH 
12    105.7, C  15"a  1.16, m  23.3, CH2 
13   153.9,  C  15"b  1.45,  m   
14  3.91, s  57.8, CH3 16"a  1.33,  m  28.6,  CH2 
15  3.99, s  56.8, CH3 16"b  1.73,  m   
1'  6.51, d (6.0)  113.5, CH  17"  1.20, m  56.2, CH 
2'  4.21, dd (9.2, 6.0)  43.0, CH  18"  0.78, s  12.8, CH3 
3'a  2.34, ddd (13.2, 9.2, 4.9)  36.9, CH2  19"  0.72, s  18.0, CH3 
3'a  2.47, d (13.2)    20"  2.00, m  39.7, CH 
4'  5.39, d (4.9)  104.2, CH  21"  0.98, d (6.6)  20.9, CH3 
1"a 1.57,  m  34.6,  CH2  22"  5.13, dd (15.3, 8.3)  135.2, CH 
1"b  1.86, m    23"  5.21, dd (15.3, 7.6)  132.3, CH 
2"a 1.13,  m  27.6,  CH2 24"  1.84,  m  42.8,  CH 
2"b  1.73, m    25"  1.45, m  33.1, CH 
3"  3.79, m  72.1, CH  26"  0.81, d (6.8)  19.6, CH3 
4"a 1.54,  m  33.6,  CH2  27"  0.83, d (6.8)  20.0, CH3 
4"b  1.91, m    28"  0.90, d (6.8)  17.6, CH3 
5"    81.8, C  OH  12.73, s   
Compound  2 was obtained as colorless crystals from CHCl3. The molecular formula was 
established to be C27H33N3O3 based on HREIMS (m/z  447.2507 [M]
+, calcd. for C27H33N3O3, 
447.2522), requiring thirteen degrees of unsaturation. The 
1H NMR spectrum (Table 2) of 2 exhibited 
five methyl singlets, two singlets characteristic of terminal olefinic protons, one double doublet and 
two doublets attributed to a terminal vinyl group, two doublets and two double doublets ascribed to an 
ortho-substituted phenyl group, and two broad singlets assigned to two presumably exchangeable 
protons. The 
13C NMR spectrum (Table 2) exhibited fifteen resonances, which were identified as five 
methyls, five methylenes, six methines, and eleven quaternary carbons by the DEPT and HSQC 
experiments. The HMBC correlations from H-3"' to C-1"', C-2"', and C-4"', from H-4"' to C-1"', C-2"', 
and C-3"', from H-5"' to C-1"', C-2"', and C-6"', and from H-6"' to C-1"', C-2"', and C-5"' established 
the presence of structural unit CH2=CH(CH3)–C(CH3)2–. The remaining NMR resonances were similar 
to those reported for brevianamide Q [10]. The major exception was the significant downfield shift of 
C-9 (δC 94.3) due to it being the site of an ether linkage to the new CH2=CH(CH3)–C(CH3)2– group. 
The structure of the remaining portion of the compound was confirmed based on 
1H–
1H COSY 
correlations between H-6/H-7, H-7/H-8, H-4'/H-5', H-5'/H-6', H-6'/H-7', H-2"/H-3", as well as HMBC 
correlations from H-1 to C-4, from H-8 to C-1 and C-9, from H-1' to C-3' and C-3a', from H-4' to C-3', 
C-6', and C-7a', from H-7' to C-3a' and C-5', from H-8' to C-4 and C-2', and from H-4" and H-5" to  Mar. Drugs 2012, 10                                                 
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C-2', C-1", and C-2". The above evidence established the structure of 2, named 9ξ-O-2(2,3-
dimethylbut-3-enyl)brevianamide Q. 
Table 2. 
1H and 
13C NMR data for compound 2  (500 MHz for 
1H and 125 MHz for  
13C, CDCl3). 
Position  δH (J in Hz)  δC, mult.  Position δH(J in Hz)  δC, mult. 
1    162.3, C  6'  7.19, dd (7.5, 8.0)  122.3, CH 
2  7.48 br, s    7'  7.35, d (8.0)  111.1, CH 
3    126.2, C  7a'    134.2, C 
4    159.4, C  8'  7.29, s  111.6, CH 
5     1"    39.3,  C 
6a 3.75,  m  45.2,  CH2  2"  6.08, dd (17.4, 10.6)  144.3, CH 
6b  3.95, m    3"a  5.21, d (17.4)  113.4, CH2 
7a 2.00,  m  19.8,  CH2  3"b  5.24, d (10.6)   
7b  2.10, m    4"  1.54, s  27.3, CH3 
8a 2.25,  m  33.5,  CH2  5"  1.54, s  27.7, CH3 
8b 2.37,  m    1"'    84.6,  C 
9    94.3, C  2"'    148.1, C 
1'  8.29 br, s    3"'a  4.89, s  111.7, CH2 
2'    144.1, C  3"'b  4.96, s   
3'    103.5, C  4"'  1.83, s  18.5, CH3 
3a'    126.2, C  5"'  1.40, s  24.0, CH3 
4'  7.47, d (7.5)  119.9, CH  6"'  1.32, s  25.0, CH3 
5'  7.13, dd (7.5, 7.5)  120.9, CH       
In addition to these two new compounds, we also isolated several known compounds including 
brevianamide K (3) [3], brevianamide M (4) [3], aversin (5) [4], 6,8-di-O-methylnidurufin (6) [5],  
6,8-di-O-methylaverufin (7) [6], 6-O-methylaverufin (8) [7], 5α,8α-epidioxyergosta-6,22-dien-3β-ol 
(9) [8], ergosta-7,22-diene-3β,5α,6β-triol (10) [9], and 6β-methoxyergosta-7,22-diene-3β,5α-diol  
(11) [9]. The structures of these metabolites were confirmed by comparisons of their respective 
spectroscopic data with those reported earlier. 
Table 3. Antibacterial activities at 30 μg/disk and toxicities against brine shrimp at   
100 μg/mL of 1–8. 
Compounds 
Inhibition Zone (mm)  Lethal Rates (%) 
Escherichia coli  Staphylococcus aureus  Artemia salina 
1  7 7  1.8 
2  7 7  43.2 
3  7 7  30.9 
4  11 10  47.6 
5  6 6  17.5 
6  7 7  29.1 
7  10 10  100.0 
8  10 10  38.5 
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Compounds 1–8 were tested for biological activities against several target organisms including 
bacteria, fungi, and brine shrimp. Antibacterial activity was assessed by disk diffusion assay against 
Escherichia coli and Staphylococcus aureus at a concentration of 30 μg/disk. Compounds 4, 7, and 8 
were found to exhibit modest inhibitory activity against these bacterial strains (Table 3). None of the 
compounds inhibited the fungal species Colletotrichum lagenarium or Fusarium oxysporium at   
30 μg/disk in the disk diffusion assay [11]. Interestingly, compound 7 exhibited significant toxicity 
toward brine shrimp with an LC50 value of 0.5 μg/mL [12]. 
3. Experimental Section 
3.1. General 
NMR spectra were recorded in CDCl3 at 500 and 125 MHz for 
1H and 
13C, respectively, on a 
Bruker Avance III 500 NMR spectrometer using TMS as internal standard. High resolution mass data 
were acquired on Autospec Premier P776 mass spectrometer with an EI source. IR spectra were 
obtained on a JASCO FT/IR-4100 Fourier Transform InfraRed spectrometer. UV spectrum was 
measured on a TU-1810 Spectrophotometer. HPLC separation was carried out o n  a n  E l i t e  H P L C  
system (P270 pump, UV230+ detector, Dalian Elite Analytical Instruments Co., Ltd., Dalian, China) 
using an Eclipse XDB-C18 (5 μm, 9.4 × 250 mm) column. Column chromatography was performed 
with silica gel (100-200 and 200–300 mesh, Qingdao Haiyang Chemical Co., Qingdao, China) and 
Sephadex LH-20 (Pharmacia). Precoated silica gel plates (GF-254, Qingdao Haiyang Chemical Co., 
Qingdao, China) were used for preparative TLC purification. All solvents were of analytical grade. 
3.2. Microorganism and Fermentation 
The endophytic fungus A. versicolor pt20 was isolated from a fresh, surface-sterilized tissue sample 
of the marine brown alga S. thunbergii, which was collected from Pingtan Island, China. The fungus 
was identified based on morphological and molecular taxonomic methods by one of the authors   
(F.-P.M.). A voucher sample has been preserved in Bio-Resource Laboratory of Yantai Institute of 
Coastal Zone Research, Chinese Academy of Sciences. The initial cultures were maintained on the 
potato dextrose agar plates. Pieces of mycelia were cut into small segments and aseptically inoculated 
into 1000 mL Erlenmeyer flasks containing 300 mL potato dextrose broth (PDB) culture media.   
The static fermentation was carried out for 30 days at room temperature (25 °C). 
3.3. Extraction and Isolation 
The culture broth (15 L) was extracted with EtOAc to yield 3.6 g gum after removal of the solvent 
by evaporation (40 °C) at reduced pressure. The dried and powdered mycelia (162.2 g) were extracted 
with a mixture of CHCl3 and MeOH (1:1, v/v), concentrated, and partitioned between H2O and EtOAc 
to give 29.8 g gum. Since the TLC profiles of the two extracts were nearly identical, they were 
combined before further separation. The total EtOAc-soluble fraction (33.4 g) was subjected to silica 
gel column chromatography (CC, petroleum ether (PE)/EtOAc gradient) to afford 16 fractions   
(Fr. 1–16), monitored by TLC. Fr. 10 eluted with PE/EtOAc (5:1) and was further purified by CC on 
Sephadex LH-20 (CHCl3/MeOH, 1:1) to yield three sub-fractions, 10-1, 10-2, and 10-3. Sub-fraction Mar. Drugs 2012, 10                                                 
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10-1 was further purified by silica gel CC (PE/EtOAc, 5:1) and HPLC (MeOH/H2O, 85%) to give 9 
(3.0 mg). Sub-fraction 10-2 was further purified by silica gel CC (PE/EtOAc, 4:1) and preparative 
TLC (CHCl3/EtOAc, 2:1) to afford 7 (13.0 mg). Sub-fraction 10-3 was further purified by silica gel 
CC (CHCl3/EtOAc, 4:1) and preparative TLC (CHCl3/EtOAc, 3:2) to produce 1 (8.3 mg). Fr. 11 eluted 
with PE/EtOAc (2:1) and was further purified by CC on Sephadex LH-20 (CHCl3/MeOH, 1:1) to 
afford 5 (27.1 mg). Fr. 12 eluted with PE/EtOAc (2:1) and was further purified by CC on Sephadex 
LH-20 (CHCl3/MeOH, 1:1) and preparative TLC (CHCl3/EtOAc, 3:2) to yield 2  (2.0 mg). Fr. 13 
eluted with PE/EtOAc (1:1) and was further purified by CC on Sephadex LH-20 (CHCl3/MeOH, 1:1) 
to produce two sub-fractions, 13-1 and 13-2. Sub-fraction 13-1 was further purified by silica gel 
(PE/EtOAc, 2:1) and preparative TLC (CHCl3/EtOAc, 2:1) to give 3 (4.3 mg). Sub-fraction 13-2 was 
further purified by CC on silica gel (PE/EtOAc, 2:1–1:1) and HPLC (MeOH /H2O, 85%) to afford 11 
(4.4 mg). Fr. 14 eluted with PE/EtOAc (1:1) and was further purified by CC on Sephadex LH-20 
(CHCl3/MeOH, 1:1) and silica gel (PE/EtOAc, 1:1) and preparative TLC (CHCl3/EtOAc, 1:1) to yield 
6 (2.0 mg). Fr. 15 eluted with EtOAc and was further purified by CC on Sephadex LH-20 
(CHCl3/MeOH, 1:1) to yield three sub-fractions, 15-1, 15-2, and 15-3. Sub-fraction 15-1 was further 
purified by CC on silica gel (PE/EtOAc, 1:2) and preparative TLC (PE/EtOAc, 1:2) to afford 8  
(10.2 mg). Sub-fraction 15-2 was further purified by CC on silica gel (CHCl3/EtOAc, 2:3) and 
preparative TLC (CHCl3/EtOAc, 2:3) to produce 4 (29.0 mg). Sub-fraction 15-3 was further purified 
by HPLC (MeOH /H2O, 85%) and preparative TLC (EtOAc) to give 10 (3.0 mg). 
Asperversin A (1): Yellow crystals; m.p. 273–275 °C; [α]
25
D −309.7 (c 0.12, CHCl3); UV (CHCl3) 
λmax (log ε) 248 (4.51), 330 (4.14) nm. IR (KBr) νmax 3448, 2927, 2866, 1631, 1581, 1485, 1369, 1234, 
972 cm
−1. 
1H and 
13C NMR data, see Table 1. HREIMS m/z 782.4024 [M]
+, calcd. for C47H58O10, 
782.4030. 
9ξ-O-2(2,3-dimethylbut-3-enyl)brevianamide Q (2): Colorless crystals; m.p. 89–92 °C; [α]
24
D −16.0 
(c 0.11, CHCl3); UV (CHCl3) λmax (log ε) 238 (3.61), 334 (3.28) nm. IR (KBr) νmax 3340, 2927, 2858, 
1693, 1624, 1427, 1385, 1238, 1149, 910, 748 cm
−1. 
1H and 
13C NMR data, see Table 2. HREIMS  
m/z 447.2507 [M]
+, calcd. for C27H33N3O3, 447.2522. 
3.4. Antimicrobial Assay 
Antibacterial and antifungal activities were assayed as described previously [11]. 
3.5. Brine Shrimp Lethality Assay 
Brine shrimp (Artemia salina) lethality assay procedure followed the micro-well plate method 
described by Solis et al with some modifications [12]. Briefly, brine shrimp eggs were left to hatch in 
sea water for 48 hours at 28 °C under natural light. For brine shrimp lethality testing, compounds were 
dissolved in DMSO prior to preparing serial dilutions in 200 µL volume of sea water prepared in  
96 well microplates. A well containing DMSO without compounds added was used as a positive 
control. Approximately, 10 brine shrimp were placed in a well with a volume of 200 µL sea water for 
lethality testing. Brine shrimp lethality was observed after 24 hours of cultivation under continuous 
light. Dead shrimp were identified with the aid of a handheld magnifying lens.  Mar. Drugs 2012, 10                                                 
 
 
138
4. Conclusions 
In summary, two new (1 and 2) and nine known (3–11) secondary metabolites were purified from 
the algicolous fungus A. versicolor pt20. To the best of our knowledge, compound 1 represented the 
first described example of a steroid-xanthone heterodimer. Compunds 4, 7, and 8 were more active 
against E. coli and S. aureus, and 7 also showed strong toxicity against brine shrimp. 
Acknowledgments 
This work was financially supported by the National Natural Science Foundation of China 
(41106137, 41106136), Chinese Academy of Sciences for Key Topics in Innovation Engineering 
(KZCX2-YW-QN209, KSCX2-EW-G-12B), and Foundation of the Chinese Academy of Sciences for 
President’s Scholarship (awarded to N.-Y. Ji). 
References 
1.  König, G.M.; Kehraus, S.; Seibert, S.F.; Abdel-Lateff, A.; Müller, D. Natural products from 
marine organisms and their associated microbes. ChemBioChem 2006, 7, 229–238. 
2.  Osterhage, C.; König, G.M.; Höller, U.; Wright, A.D. Rare sesquiterpenes from the algicolous 
fungus Drechslera dematioidea. J. Nat. Prod. 2002, 65, 306–313. 
3.  Li, G.Y.; Yang, T.; Luo, Y.G.; Chen, X.Z.; Fang, D.M.; Zhang, G.L. Brevianamide J, a new 
indole alkaloid dimer from fungus Aspergillus versicolor. Org. Lett. 2009, 11, 3714–3717. 
4.  Shao, C.; She, Z.; Guo, Z.; Peng, H.; Cai, X.; Zhou, S.; Gu, Y.; Lin, Y. Spectral assignments and 
reference data. Magn. Reson. Chem. 2007, 45, 434–438. 
5.  Kingston, D.G.I.; Chen, P.N.; Vercellotti, J.R. Metabolites of Aspergillus versicolor.  
6,8-di-Ο-methylnidurufin, griseofulvin, dechlorogriseofluvin, and 3,8-dihydroxy-6-methoxy-1-
methylxanthone. Phytochemistry 1976, 15, 1037–1039. 
6.  Ren, H.; Gu, Q.Q.; Cui, C.B. Anthraquinone derivatives produced by marine-derived Penicillium 
flavidorsum SHK1-27 and their antitumor activities. Chin. J. Med. Chem. 2007, 17, 148–154. 
7.  Steyn, P.S.; Vleggaar, R.; Wessels, P.S.; Cole, R.J.; Scott, D.B. Structure and carbon-13 nuclear 
magnetic resonance assignments of versiconal acetate, versiconol acetate, and versiconol, 
metabolites from cultures of Aspergillus parasiticus treated with ditchlorvos. J. Chem. Soc. 
Perkin Trans. I 1979, 451–459. 
8.  Greca, M.D.; Mangoni, L.; Malinaro, A.; Monaco, P.; Previtera, L. 5β,8β-Epidioxyergosta-6,22-
dien-3β-ol from Typha latifolia. Gazz. Chim. Ital. 1990, 120, 391–392. 
9.  Kawagishi, H.; Katsumi, R.; Sazawa, T.; Mizuno, T.; Hagiwara, T.; Nakamura, T. Cytotoxic 
steroids from the mushroom Agaricus blazei. Phytochemistry 1988, 27, 2777–2779. 
10. Li, G.Y.; Li, L.M.; Yang, T.; Chen, X.Z.; Fang, D.M.; Zhang, G.L. Four new alkaloids, 
brevianamides O–R, from the fungus Aspergillus versicolor.  Helv. Chim. Acta  2010,  93,  
2075–2080. 
11.  Schulz, B.; Sucker, J.; Aust, H.J.; Krohn, K.; Ludewig, K.; Jones, P.G.; Döring, D. Biologically 
active secondary metabolites of endophytic Pezicula species. Mycol. Res. 1995, 99, 1007–1015. Mar. Drugs 2012, 10                                                 
 
 
139
12. Solis, P.N.; Wright, C.W.; Anderson, M.M.; Gupta, M.P.; Phillipson, J.D. A microwell 
cytotoxicity assay using Artemia salina (brine shrimp). Planta Med. 1993, 59, 250–252. 
Samples Availability: Available from the authors. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 